Saturna Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Saturna Capital's BSX Position: Q2 2026 in Review
Saturna Capital reduced its Boston Scientific (BSX) stake by 58% in Q2 2026, selling an estimated $1.35M and leaving 17,835 shares worth $761K. The position accounts for 0.01% of the portfolio, ranked #99.
Saturna Capital first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.49M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Saturna Capital held 17,835 shares of Boston Scientific worth $761K as of Q2 2026.
- Saturna Capital sold 24,952 Boston Scientific shares in Q2 2026, an estimated $1.35M.
- Boston Scientific made up 0.01% of Saturna Capital's portfolio in Q2 2026, its #99 holding.
- Saturna Capital first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
- Saturna Capital's Boston Scientific position peaked at $4.49M in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Saturna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.